🚀 VC round data is live in beta, check it out!
Fragua Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fragua and similar public comparables like Ebos Group, Sundrug, DaShenLin Pharmaceutical, Kusuri No Aoki and more.
Fragua Overview
About Fragua
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
Founded
1992
HQ
Employees
36.9K
Website
Sectors
Financials (LTM)
EV
$3B
Fragua Financials
Fragua reported last 12-month revenue of $8B and EBITDA of $573M.
In the same LTM period, Fragua generated $573M in EBITDA and $287M in net income.
Revenue (LTM)
Fragua P&L
In the most recent fiscal year, Fragua reported revenue of $7B and EBITDA of $361M.
Fragua expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $8B | XXX | $7B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $573M | XXX | $361M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $287M | XXX | $277M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fragua Stock Performance
Fragua has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Fragua's stock price is $30.33.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | (0.6%) | XXX | XXX | XXX | $2.89 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFragua Valuation Multiples
Fragua trades at 0.4x EV/Revenue multiple, and 4.8x EV/EBITDA.
EV / Revenue (LTM)
Fragua Financial Valuation Multiples
As of March 7, 2026, Fragua has market cap of $3B and EV of $3B.
Equity research analysts estimate Fragua's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fragua has a P/E ratio of 10.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 4.8x | XXX | 7.6x | XXX | XXX | XXX |
| EV/EBIT | 5.4x | XXX | 10.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.7x | XXX | XXX | XXX |
| P/E | 10.1x | XXX | 10.5x | XXX | XXX | XXX |
| EV/FCF | 19.8x | XXX | 847.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fragua Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Fragua Margins & Growth Rates
Fragua's revenue in the last 12 month grew by 5%.
Fragua's revenue per employee in the last FY averaged $0.2M.
Fragua's rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fragua's rule of X is 19% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Fragua Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 57% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 12% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fragua Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ebos Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Sundrug | XXX | XXX | XXX | XXX | XXX | XXX |
| DaShenLin Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Kusuri No Aoki | XXX | XXX | XXX | XXX | XXX | XXX |
| Nahdi Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fragua M&A Activity
Fragua acquired XXX companies to date.
Last acquisition by Fragua was on XXXXXXXX, XXXXX. Fragua acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fragua
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFragua Investment Activity
Fragua invested in XXX companies to date.
Fragua made its latest investment on XXXXXXXX, XXXXX. Fragua invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fragua
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fragua
| When was Fragua founded? | Fragua was founded in 1992. |
| Where is Fragua headquartered? | Fragua is headquartered in Mexico. |
| How many employees does Fragua have? | As of today, Fragua has over 36K employees. |
| Is Fragua publicly listed? | Yes, Fragua is a public company listed on Bolsa Mexicana de Valores. |
| What is the stock symbol of Fragua? | Fragua trades under FRAGUAB ticker. |
| When did Fragua go public? | Fragua went public in 1997. |
| Who are competitors of Fragua? | Fragua main competitors are Ebos Group, Sundrug, DaShenLin Pharmaceutical, Kusuri No Aoki. |
| What is the current market cap of Fragua? | Fragua's current market cap is $3B. |
| What is the current revenue of Fragua? | Fragua's last 12 months revenue is $8B. |
| What is the current revenue growth of Fragua? | Fragua revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Fragua? | Current revenue multiple of Fragua is 0.4x. |
| Is Fragua profitable? | Yes, Fragua is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Fragua? | Fragua's last 12 months EBITDA is $573M. |
| What is Fragua's EBITDA margin? | Fragua's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Fragua? | Current EBITDA multiple of Fragua is 4.8x. |
| What is the current FCF of Fragua? | Fragua's last 12 months FCF is $139M. |
| What is Fragua's FCF margin? | Fragua's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Fragua? | Current FCF multiple of Fragua is 19.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.